Bontemps Invest SRL
Bontemps Invest reported total assets of €1.45m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Sep 2026).
By total assets for 2025, Bontemps Invest ranks among the 1,000 largest of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Bontemps Invest shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Bontemps Invest's annual accounts
| 2025 | |
|---|---|
| Net result | −49,161 € |
| Equity | −29,161 € |
| Cash | 2,463 € |
| EBITDA | −44,193 € |
| Total assets | €1.45m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
Bontemps Invest's financial analysis
- Solvency-2.0%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Bontemps Invest
Bontemps Invest's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1020.187.404
- VAT number
- BE1020187404
- Peppol
- Registered · 0208:1020187404 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Feb 2025
- Registered office
- 1020 Brussels
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Bontemps Invest (SRL) has been based in Brussels since 2025, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 49,161 € and equity of −29,161 €; its revenue is not published. Its solvency stands at -2.0%, below the median of its sector (37.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Bontemps Invest
Companies in the same business, of comparable size and area, outside its group.
- Jeandarme Manufacture of pharmaceutical preparations Sint-Truiden · balance sheet €1.60m
- Sobegapharma Manufacture of basic pharmaceutical products Mons · balance sheet €1.04m
- Reprobiol Manufacture of basic pharmaceutical products Ouffet · balance sheet €1.93m
- Pharma Werbomont Retail sale of pharmaceutical products Ferrières · balance sheet €1.35m
- Thomas Paesen Retail sale of pharmaceutical products Oudsbergen · balance sheet €1.46m
- Dynarop Products Retail sale of pharmaceutical products Mouscron · balance sheet €1.19m
- Codema Pharma Retail sale of pharmaceutical products Brussels · balance sheet 375,959 €
- Apotheek Paleis Retail sale of pharmaceutical products Antwerp · balance sheet €1.59m
Frequently asked questions about Bontemps Invest
What is the revenue of Bontemps Invest?
Bontemps Invest files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Bontemps Invest?
In Belgium, the VAT number is the company number prefixed with BE: BE1020187404 for Bontemps Invest, if the company is VAT-registered. Its company number (CBE) is 1020.187.404.
Where is the registered office of Bontemps Invest?
According to the CBE register, the registered office of Bontemps Invest is in 1020 Brussels.
What is the equity of Bontemps Invest?
At the close of the 2025 financial year, the equity of Bontemps Invest amounts to -29,161 €, a solvency of -2.0% of total assets.
Who manages Bontemps Invest?
The register lists 2 active mandates at Bontemps Invest. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Bontemps Invest within its sector?
By total assets for 2025, Bontemps Invest ranks among the 1,000 largest of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year.
The full file of Bontemps Invest
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →